TY  - JOUR
AU  - Blocka, Joanna
AU  - Hielscher, Thomas
AU  - Mueller-Tidow, Carsten
AU  - Goldschmidt, Hartmut
AU  - Hillengass, Jens
TI  - Salvage therapy versus upfront autologous stem cell transplantation in multiple myeloma patients with progressive disease after first-line induction therapy.
JO  - Leukemia and lymphoma
VL  - 61
IS  - 1
SN  - 1029-2403
CY  - London [u.a.]
PB  - Taylor & Francis Group
M1  - DKFZ-2019-02014
SP  - 27-36
PY  - 2020
N1  -  2020 Jan;61(1):27-36
AB  - It is a matter of debate whether myeloma patients with progressive disease (PD) after induction should receive salvage therapy or proceed directly to autologous stem cell transplantation. We performed a retrospective analysis of 1599 patients treated between 1991 and 2016 at the University Hospital of Heidelberg and other centers. Deepening of response through salvage therapy did not lead to better progression-free or overall survival (PD versus salvage therapy patients: HR = 0.71, 95
LB  - PUB:(DE-HGF)16
C6  - pmid:31423866
DO  - DOI:10.1080/10428194.2019.1646905
UR  - https://inrepo02.dkfz.de/record/144571
ER  -